India OKs Abbott's FreeStyle Libre Pro glucose monitoring system

India approves Abbott's FreeStyle Libre Pro Flash system, featuring a patient-worn sensor that logs blood sugar levels for up to 14 days.

Regulators in India approved a glucose monitoring system made by Abbott (NYSE:ABT) that's designed to track patients' blood sugar levels for up to 2 weeks.

Abbott Laboratories

News Well, Diabetes, Exports

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1GDs9T0